UNH vs CVS: UnitedHealth Built the Premium Healthcare Platform; CVS Is Still Paying for Its Acquisitions
UnitedHealth is the most profitable company in American healthcare — its Optum division turned data and pharmacy benefit management into a $150B+ annual revenue stream. CVS transformed from a drugstore chain into a healthcare conglomerate via three massive acquisitions. Both own large pieces of US healthcare infrastructure. But their margin profiles, debt loads, and growth trajectories tell very different stories.
The Core Difference
UNH runs a vertically integrated healthcare system. United Healthcare insures 50M+ Americans; Optum manages pharmacy benefits, provides physician and clinic services, and runs a healthcare analytics business. The two divisions reinforce each other — Optum's data capabilities give United Healthcare a cost management advantage that pure insurers cannot replicate. This integration is why UNH earns operating margins of 8–9%, far above typical insurance industry norms.
CVS is a different kind of integration. It anchors in retail pharmacy (9,000+ US stores), runs CVS Caremark (pharmacy benefit management), Aetna (health insurance), and Oak Street Health (primary care clinics). The vision is a one-stop-shop for healthcare that removes the friction between pharmacy, primary care, and insurance. The execution has been slower than the strategy promised — and the $50B+ in acquisition debt limits what CVS can do next.
Business Comparison
- Insurance + Optum health services platform
- $430B+ revenue, ~9% operating margin
- ~1.5% yield, 12–15%/yr dividend growth
- Change Healthcare cyberattack cost $1B+
- Medical cost ratio risk in post-COVID utilization surge
- Premium valuation — always expensive
- Pharmacy + PBM + insurance + clinics
- $375B+ revenue, ~5% operating margin
- ~3–4% yield, slow dividend growth
- $50B+ acquisition debt (Aetna, Oak Street, Signify)
- Retail pharmacy traffic declining structurally
- Discount valuation — cheap for a reason
Why UNH Trades at a Premium
The market pays a premium for UNH because Optum has become a durable competitive advantage that is genuinely hard to replicate. When UNH insures someone, Optum can manage their pharmacy costs, direct them to UNH-affiliated physicians, and use predictive analytics to catch expensive conditions early. The data flywheel compounds over time in a way that a pure insurer cannot copy quickly.
The risk is that this integration has attracted regulatory attention. Politicians across both parties have targeted health insurer profitability, and UNH's scale makes it the primary target. The Change Healthcare cyberattack — which took down payment processing for nearly half of US healthcare providers in early 2024 — was a stark illustration of the systemic risk that comes with being this deeply embedded in US healthcare infrastructure.
Who Should Buy Which
Technical Signals — What to Watch
Both UNH and CVS are driven heavily by earnings results and healthcare policy news. Medical cost ratio (MCR) for UNH and prescription volume trends for CVS are the key fundamental numbers to watch in quarterly reports.
- RSI: UNH RSI below 45 has historically been a buying opportunity in the absence of a fundamental earnings miss — the market tends to overreact to single-quarter MCR deterioration.
- MACD: CVS MACD signals work best in quarterly earnings cycles — watch for crossovers following the initial post-earnings reaction to confirm direction.
- Volume: Political news about Medicare/Medicaid reimbursement changes drives unusual volume on both names — these are often short-term overreactions.
APEX scores both stocks daily across RSI, MACD, moving averages, volume, and 52-week position. Updated every market day.
Compare UNH vs CVS Live →